Polar Capital Funds PLC - Polar Capital Healthcare Opportunities Fund R IncRegister to Unlock Ratings |
Performance History | 31/10/2024 |
Growth of 1,000 (GBP) | Advanced Graph |
Fund | 14.5 | 9.4 | 2.6 | 3.4 | 14.3 | |
+/-Cat | -2.9 | 0.0 | 7.3 | 6.5 | 10.5 | |
+/-B’mrk | - | -8.8 | -3.2 | 5.9 | 6.9 | |
Category: Sector Equity Healthcare | ||||||
Category Benchmark: Morningstar Gbl Health TME ... |
Key Stats | ||
NAV 06/11/2024 | USD 77.64 | |
Day Change | 1.37% | |
Morningstar Category™ | Sector Equity Healthcare | |
ISIN | IE00B3NLTK32 | |
Fund Size (Mil) 06/11/2024 | USD 1932.63 | |
Share Class Size (Mil) 06/11/2024 | USD 261.30 | |
Max Initial Charge | 5.00% | |
Ongoing Charge 30/06/2024 | 1.61% |
Investment Objective: Polar Capital Funds PLC - Polar Capital Healthcare Opportunities Fund R Inc |
The investment objective of the Fund is to preserve capital and achieve long term capital appreciation. The Fund will seek to achieve its investment objective by investing in a globally diversified portfolio of healthcare companies. The Fund will at all times invest at least two thirds of its total assets (excluding cash) in healthcare-related companies worldwide. The Fund will invest at least 51% of its gross assets on a continuous basis directly in Equity Participations. Subject to the investment restrictions described in Appendix II of the Prospectus, investments will be made in transferable securities including, but not limited to, shares, equity warrants and other types of securities such as preferred shares, which may be listed on a Regulated Market or unlisted, and issued by companies, and Global, American and European depository receipts. The Fund may not invest more than 10% of its Net Asset Value in unlisted securities. |
Returns | ||||||||||||||||
|
Management | ||
Manager Name Start Date | ||
Gareth Powell 03/12/2007 | ||
James Douglas 30/09/2015 | ||
Inception Date 01/04/2009 |
Advertisement |
Category Benchmark | |
Fund Benchmark | Morningstar Benchmark |
MSCI ACWI/Health Care NR EUR | Morningstar Gbl Health TME NR USD |
Target Market | ||||||||||||||||||||
|
Portfolio Profile for Polar Capital Funds PLC - Polar Capital Healthcare Opportunities Fund R Inc | 30/09/2024 |
|
|
Top 5 Holdings | Sector | % |
Swedish Orphan Biovitrum AB | Healthcare | 9.77 |
Zealand Pharma AS | Healthcare | 7.79 |
Novo Nordisk AS Class B | Healthcare | 6.46 |
UCB SA | Healthcare | 5.82 |
Sanofi SA | Healthcare | 4.49 |
Increase Decrease New since last portfolio | ||
Polar Capital Funds PLC - Polar Capital Healthcare Opportunities Fund R Inc |